Pomegranate Juice and Metabolic Syndrome

The effect of pomegranate juice (PJ) intake on cardiovascular risks in subject with metabolic syndrome in shabestar.

Inclusion criteria

• presence of ≥3 of the following diagnostic of MetS:

• serum TGs of at least 150 mg/dL,
• waist circumference of more than 102 cm (40 in) in men and more than 88 cm (35 in) in women,
• high-density lipoprotein (HDL) level less than 40 mg/dL in men and less than 50 mg/dL in women,
• blood pressure 135/85 mm Hg or higher, or
• fasting glucose 100 mg/dL or Higher

Exclusion criteria

• liver cirrhosis,
• chronic pancreatitis,
• gastrointestinal or connective diseases,
• kidney stones, or
• renal failure,
• alcohol Consumption,
• having an allergy to pomegranate juice,
• a change in diet,
• the large increase in LDL so that required drug treatment.
• use of statins of fibrates, corticosteroids, nitrates, acetyl-salicylic acid or other anti-platelet drugs, oral hypoglycemic drugs, nonsteroidal anti-inflammatory drugs, or drugs interfering with coagulation;
• pregnancy or lactation in the past 6 mo, supplementation with vitamins or antioxidants